Literature DB >> 12441070

Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure.

P Roques1, D L Robertson, S Souquière, F Damond, A Ayouba, I Farfara, C Depienne, E Nerrienet, D Dormont, F Brun-Vézinet, F Simon, P Mauclère.   

Abstract

We assess the genetic relationships between 49 HIV-1 group O strains from 24 and 25 patients living in Cameroon and France, respectively. Strains were sequenced in four genomic regions: gag (p24) and three env regions (C2-V3, gp41, and for 22 C2-gp41). In each of the genomic regions analyzed, the genetic diversity among the group O strains was higher than that exhibited by group M. We characterize three major group O phylogenetic clusters (O:A, O:B, and O:C) that comprised the same virus strains in each of the genomic regions analyzed. The majority of strains cluster in O:A, a cluster previously identified by analysis of pol and env sequences. Group O recombinants were also identified. Importantly, the distinction between these three major group O clades was weak compared to the strong clustering apparent in the global group M phylogenetic tree that led to the identification of subtypes. Thus, these clusters of group O viruses should not be considered as equivalent to the group M subtypes. This difference between the pattern of group O and the global group M diversity, both taking into account the pandemic status of the group M subtypes and the comparatively small number of group O-infected individuals (the majority being from Cameroon), indicates that the group O phylogeny primarily represents viral divergence in the Cameroon region, analogous to group M viral diversity present in the Democratic Republic of Congo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441070     DOI: 10.1006/viro.2002.1430

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  The molecular population genetics of HIV-1 group O.

Authors:  Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Alexei J Drummond; David L Robertson; Pierre Roques; Michael Worobey; Anne-Mieke Vandamme
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

2.  Characterization of HIV type 1 envelope sequence among viral isolates circulating in the northern region of Colombia, South America.

Authors:  José-Luis Villarreal; Jaime Gutiérrez; Lucy Palacio; Martha Peñuela; Robin Hernández; Guy Lemay; Guillermo Cervantes-Acosta
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-21       Impact factor: 2.205

3.  Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.

Authors:  Agnès Depatureaux; Charlotte Charpentier; Gilles Collin; Marie Leoz; Diane Descamps; Aurélia Vessière; Florence Damond; Dominique Rousset; Françoise Brun-Vézinet; Jean-Christophe Plantier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.

Authors:  Said Zouhair; Sylvie Roussin-Bretagne; Alain Moreau; Sylvie Brunet; Syria Laperche; Michèle Maniez; Francis Barin; Martine Harzic
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Human Immunodeficiency Virus (HIV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-05-09       Impact factor: 3.747

6.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

7.  HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.

Authors:  Christian Julian Villabona-Arenas; Jenny Domyeum; Fatima Mouacha; Christelle Butel; Eric Delaporte; Martine Peeters; Eitel Mpoudi-Ngole; Avelin Fobang Aghokeng
Journal:  Infect Genet Evol       Date:  2015-09-11       Impact factor: 3.342

8.  Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.

Authors:  Maud Salmona; Severine Delarue; Constance Delaugerre; François Simon; Sarah Maylin
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

9.  Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.

Authors:  Véronique Lemee; Marie Leoz; Manuel Etienne; Fabienne De Oliveira; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2014-06-25       Impact factor: 5.948

10.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.